InnoPath Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
InnoPath Therapeutics is developing a platform of first-in-class topical therapeutics to revolutionize the treatment of non-melanoma skin cancer for the tens of millions of people who get skin cancer and pre-cancer each year.InnoPath Therapeutics will unlock 50 million new patients and $10B in revenue annually by offering innovative, safe, and effective therapies. Currently pre-clinical, we’ve selected our lead compound, filed five patents, and initiated animal studies and formulation development.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}